COVID-19 Vaccine Trial: Oxford Set To Release Data.
The novel Coronavirus spreads easily and the majority of the world’s population is still vulnerable to it. A vaccine would provide some protection by training people’s immune systems to fight the virus so they should not become sick.
As of 20th July, over 2.5 million cases have been reported in Europe, the five countries reporting most cases are Russia with 771 546, United Kingdom with 294 792, Spain with 260 255, Italy with 244 434 and Germany with 201 823 cases according to the European Centre for Disease Prevention and Control.
The Oxford University and AstraZeneca, will be releasing the data for the early stages of the human trials 20 July, both jointly works in the development of vaccine for the novel disease. The Oxford university vaccine candidate is currently in the third phase of human trials that are being carried out in Brazil.
“We expect this paper, which is undergoing final editing and preparation, to be published on Monday, July 20, for immediate release,” the Spokesperson of the journal was quoted as saying by Reuters.
WHAT TO KNOW
According to Developers of the Oxford vaccine, known as AZD1222, said earlier this month they were encouraged by the immune response they had seen in trials so far and we’re expecting to publish Phase 1 data by the end of July.
- Double Protection Against COVID-19: Encouraging media reports have emerged claiming that the Oxford University vaccine has made great inroads in finding protection against COVID-19. AstraZeneca-backed vaccine candidates might be able to provide ‘double protection’ against the highly infectious coronavirus.
- Production of T-cells: The vaccine in question will likely trigger the production of both the protective antibodies and ‘killer T-cells’ in the body. This has reinstated hope that the vaccine might be able to provide much-needed immunity against coronavirus. A coronavirus vaccine developed by the University of Oxford appears safe and triggers an immune response, BBC reported.
- Vaccine available by September?: One of the most positive pieces of news that has come out in the recent gloom surrounding COVID-19 is the fact that the Oxford University breakthrough could be able to provide a fully functional COVID-19 vaccine by September. As per a report published in PTI, David Carpenter, chairman, Berkshire Research Ethics Committee (which approved the Oxford trials) said that “that vaccine could be fairly widely available around September and that is the sort of target they are working on.”
The result will be published on Monday.
INCASE YOU MISSED IT:Iceland Offers World’s Screams Broadcasting To Relief COVID-19 Stress, See Details
SHARE THIS ARTICLE
Weigh in your thoughts in the comment section